You are here: Industry Insights > patent

News List

Patent fights jump in 2017 as Eli Lilly, Pfizer, Sanofi and more sue to protect their meds fiercepharma
May 07, 2018
In the ever-raging war between generic drugmakers and branded pharma, patent litigation is a standard-issue weapon. It's a high-stakes business as generics makers aim to grow their sales by rolling out copies of blockbuster drugs...
Eagle Pharma receives New Patent for Biologics biospectrumasia
April 02, 2018
The patent is directed to a technology that allows for the formulation of antibodies at high concentration
U.S. Patent and Trademark Office Awards BioPharmX Patent Protection for Novel Tetracycline-class Top biospace
March 21, 2018
BioPharmX Corporation announced today that the U.S. Patent and Trademark Office granted the company's first patent
CHA Biotech receives patent for stem cell culture medium biospectrumasia
February 26, 2018
CHA Biotech and CHA BIO F&C each own 50 percent of the patent.
Current Situation of Biosimilars in China II: 2016-2020 will be the Prime Time of Biosimilars Tang
January 15, 2018
The Chinese biosimilar market can reach RMB 20-30 billion in 2020...
Fooya! founder in patent war over digital vaccine with US Pharma giant economictimes.indiatimes
December 27, 2017
Fooya! founder and inventor of 'digital vaccine' technology Bhargav Sri Prakash has run into a trademark war with USD 5-billion pharma giant Moderna Therapeutics.
Gilead’s patent for ‘Hepatitis C’ be challenged by MSF biospectrumasia
December 19, 2017
MSF challenges Gilead’s patent application for hepatitis C combination treatment in China, to bring down prices
FIT Biotech granted U.S. patent for treating HIV biospectrumasia
December 05, 2017
FIT Biotech granted U.S. patent for treating HIV The patent grants the Company exclusive rights to exploit its GTU®-based DNA vaccines, including FIT-06, for the treatment of HIV patients.
US FDA introduces patent submission date updates to Orange Book expressbpd
November 23, 2017
The FDA is publishing this data to improve transparency and provide additional information to regulated industry and the public
Bristol-Myers Squibb nixes 58 marketing jobs as HIV medications near patent cliff fiercepharma
August 10, 2017
Six of the workers set to lose their posts in Bristol-Myers HIV unit live in New Jersey, while 52 work remotely.

Previous page 1 2 3 4 5 6 Next page